Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Frontiers in Pharmacology
|
November 29, 2023
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire
Jochen G Mainz, Anton Barucha, Pu Huang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
April 11, 2013
Therapy of CF-patients with amitriptyline and placebo--a randomised, double-blind, placebo-controlled phase IIb multicenter, cohort-study
Lutz Nährlich, Jochen G Mainz, Constantin Adams, et al.
European Radiology
|
October 20, 2021
Ultrashort echo time MRI of the lung in children and adolescents: comparison with non-enhanced computed tomography and standard post-contrast T1w MRI sequences
Diane M Renz, Karl-Heinz Herrmann, Martin Kraemer, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 6, 2024
A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI)
Alexander Yule, Christabella Ng, Arantxa Recto, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
January 3, 2024
ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis
Michael Wilschanski, Anne Munck, Estefania Carrion, et al.
The Journal of Clinical Investigation
|
January 26, 2023
Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis
Carsten Schwarz, Patience Eschenhagen, Henrijette Schmidt, et al.
Plos One
|
November 19, 2016
Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus
Sibylle Junge, Dennis Görlich, Martijn den Reijer, et al.
Pneumologie (Stuttgart, Germany)
|
February 13, 2024
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa]
Carsten Schwarz, Jutta Bend, Helge Hebestreit, et al.
Pneumologie (Stuttgart, Germany)
|
February 29, 2024
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa]
Carsten Schwarz, Jutta Bend, Helge Hebestreit, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Frontiers in Pharmacology
|
November 29, 2023
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire
Jochen G Mainz, Anton Barucha, Pu Huang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
April 11, 2013
Therapy of CF-patients with amitriptyline and placebo--a randomised, double-blind, placebo-controlled phase IIb multicenter, cohort-study
Lutz Nährlich, Jochen G Mainz, Constantin Adams, et al.
European Radiology
|
October 20, 2021
Ultrashort echo time MRI of the lung in children and adolescents: comparison with non-enhanced computed tomography and standard post-contrast T1w MRI sequences
Diane M Renz, Karl-Heinz Herrmann, Martin Kraemer, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 6, 2024
A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI)
Alexander Yule, Christabella Ng, Arantxa Recto, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
January 3, 2024
ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis
Michael Wilschanski, Anne Munck, Estefania Carrion, et al.
The Journal of Clinical Investigation
|
January 26, 2023
Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis
Carsten Schwarz, Patience Eschenhagen, Henrijette Schmidt, et al.
Plos One
|
November 19, 2016
Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus
Sibylle Junge, Dennis Görlich, Martijn den Reijer, et al.
Pneumologie (Stuttgart, Germany)
|
February 13, 2024
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa]
Carsten Schwarz, Jutta Bend, Helge Hebestreit, et al.
Pneumologie (Stuttgart, Germany)
|
February 29, 2024
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa]
Carsten Schwarz, Jutta Bend, Helge Hebestreit, et al.
Page
of 8